Nicole Maldonado accepts new patients on Medical News Today.
Nicole Maldonado
Be the first to review this provider!
Leominster, MA
Accepting new patients
Clinical Overview
Nicole Maldonado works in Leominster, MA as
Office Locations
-
Community Healthlink Adult Outpatient Services Including Primary Care40 Spruce St, Leominster, MA 01453
Patient Experience & Satisfaction
Be the first to leave a review
How likely are you to recommend Nicole Maldonado?
Step 1 of 3
Your review of Nicole Maldonado
50 characters remaining
1000 characters remaining
Was this a Telehealth appointment?
(This will display with your review)
Your email is used to confirm your review and will NOT appear in the review.
This name will appear with your review. If left blank, we'll use "Anonymous".
RVO Health property, Medical News Today, is owned by RVO Health. Please review our terms of use for more.
Help other patients find the right care by sharing a few more details about your visit.
Last step! Confirm your email.
We've sent an email to
Once you confirm, you can close this window.
Thank you for your review!
Your review has been confirmed and will be published after verification.
Thank you for your review!
We've sent a confirmation email. Your review will appear after you confirm it.
Please allow up to 30 seconds for the email to arrive. Don't see it? Make sure to check your 'spam' and 'updates' folder. Once you've confirmed your review, you can close this window.
Medical Expertise & Background
Specialties*
Counseling
- *Medical News Today does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.
Common Patient Questions
Nicole Maldonado's office is located at 40 Spruce St Leominster, MA 01453. Get a map and directions to Nicole Maldonado's office here.
Nicole Maldonado does not have any reviews yet.
Claim Your Profile
Are you Nicole Maldonado?
Know Before You Go
Preventive care: what doctors want you to know
Preventive care can help identify current or future health and medical concerns before they become major.
Featured Stories
The FDA has approved Moderna's new mRNA flu vaccine for adults ages 50 years and older. Moderna expects the vaccine to be available in the United States for the 2026 to 2027 flu season.
A natural compound derived from plant foods containing a certain type of polyphenol may help improve heart function in people with heart failure, a study in animals and human tissue models has found.
Moderna and Merck's neoantigen treatment, combining a personalized mRNA cancer vaccine with the immunotherapy drug pembrolizumab significantly reduced the risk of melanoma recurrence in a phase 3 trial.
